ClinicalTrials.gg
CompletedNCT07950241Updated Nov 20, 2026

Color Temperature of Light for Emotional States and Sleep in Insomnia

An interventional study of Light exposure, 2700 K and Light exposure, 4000 K in Insomnia, sponsored by Taipei Medical University. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 4 years 7 months after the study started (first participant enrolled Apr 2022, registered Nov 2026).
Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University — 10 open to participants now, 10 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Taipei Medical University.

Enrollment
15th of 19
30 · median 60
Started
2022
with 6 others
No phase
19 of 21
10 open now
Registered
21st of 21
by date

Among the 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, this one is the 15th largest by enrollment of the 19 interventional ones that give a count, is one of 7 that started in 2022, is one of 19 with no phase, and was the 21st registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

10 of the 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University are open now, in 2 countries. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 20 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, or all of them as a file.
02

Study summary

This pilot randomized study examined how the color temperature of light affects emotional states and sleep in people with insomnia symptoms. Thirty participants with an Insomnia Severity Index (ISI) score of 8 or higher were randomly allocated to 500-lux light at 2700 K, 4000 K or 6500 K. After a 7-day baseline, participants received a daily 75-minute light exposure session at 17:00 for 7 days (15 minutes of dark adaptation followed by 60 minutes of light), followed by a 7-day follow-up. Insomnia severity, depression, anxiety and stress were assessed on days 1 and 21, and sleep was recorded with actigraphy and sleep logs.

Read the detailed description

Sleep and emotional states are closely linked, and chronic sleep disturbance contributes to low mood. Light is the main external cue for the circadian system. Its non-visual effects are mediated mainly by melanopsin-containing retinal ganglion cells, which are most sensitive to short-wavelength light near 480 nm. At equal illuminance, white light with a higher color temperature has a higher melanopic equivalent daylight illuminance (melanopic EDI). Studies in healthy young adults show that higher color temperatures increase alertness and melatonin suppression, but whether repeated exposure to different color temperatures affects insomnia severity, actigraphic sleep and emotional states in people with insomnia has not been examined.

This study compared three color temperatures commonly used in LED lighting (2700 K warm white, 4000 K neutral white and 6500 K cool white) at a fixed photopic illuminance of 500 lux, a level typical of indoor lighting rather than a clinical light-therapy dose. It was hypothesized that, compared with 6500 K, lower color temperatures (2700 K and, to a lesser extent, 4000 K) would be associated with (1) greater reductions in insomnia severity, (2) improved actigraphic sleep (shorter sleep latency, higher sleep efficiency and longer total sleep time) and (3) lower anxiety, depression and stress.

This three-arm, parallel-group pilot randomized study was conducted at Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. Participants were referred from the sleep center, psychiatric outpatient clinic, day-care center and psychologist outpatient clinic. Each participant took part for 21 days: days 1-7 baseline, days 8-14 daily light exposure, and days 15-21 follow-up. An a priori sample size of 53 was calculated (G*Power 3.1; ANCOVA, three groups, two covariates, α = 0.05, power = 0.80, f = 0.50), but recruitment was limited by the COVID-19 pandemic and the need for daily on-site sessions, so 30 participants were enrolled and the study was treated as a pilot.

The primary between-group analysis compared change scores (posttest - pretest) across the three groups with the Kruskal-Wallis test, followed by Mann-Whitney U tests. Within-group changes were examined with the Wilcoxon signed-rank test. As a secondary analysis, one-way ANCOVA was applied to posttest scores with the pretest score and caffeine intake as covariates. The Holm procedure was used to correct for multiple testing across the seven outcomes.

03

Conditions studied

  • Insomnia

Keywords

  • Anxiety
  • Insomnia
  • Light exposure
  • Low Color Temperature
  • Sleep
04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 20 to 90 years
  • Insomnia Severity Index score of 8 or higher
  • Adequate cognitive function and clear consciousness
  • Able to follow instructions
  • Provided written

Exclusion criteria

Exclusion Criteria:

- Visual impairment, cognitive deficits or communication impairments that prevent adherence to the study protocol

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    2700 K group

    Participants will receive 2700 K (warm white) light at 500 lux, 75 minutes daily at 17:00 for 7 consecutive days. This is the reference condition.

    Other: Light exposure, 2700 K

  • Experimental
    4000 K group

    Participants will receive 4000 K (neutral white) light at 500 lux, 75 minutes daily at 17:00 for 7 consecutive days.

    Other: Light exposure, 4000 K

  • Experimental
    6500 K group

    Participants will receive 6500 K (cool white) light at 500 lux, 75 minutes daily at 17:00 for 7 consecutive days.

    Other: Light exposure, 6500 K

Interventions

  • OtherLight exposure, 2700 K

    On study days 8-14, a daily 75-minute session starting at 17:00: 15 minutes of dark adaptation in a fully blacked-out room, then 60 minutes of 2700 K light at 500 lux from an adjustable LED light box (63.5 × 63.5 × 14.5 cm panel with 2200 K and 6500 K LED chip sets mixed by power ratio). The light box is 96 cm from the participant with its center at eye level. Measured at eye position with a UPRtek MK350N Plus spectrometer: 473 lux, 2659 K, melanopic EDI 205.3 lux. Participants wear white or light-colored clothing and may read, but may not use electronic devices.

  • OtherLight exposure, 4000 K

    Same procedure, with the light box set to 4000 K at 500 lux (measured: 545 lux, 4124 K, melanopic EDI 365.1 lux).

  • OtherLight exposure, 6500 K

    Same procedure, with the light box set to 6500 K at 500 lux (measured: 497 lux, 6443 K, melanopic EDI 430.9 lux).

06

What researchers measure

Primary outcomes

  1. Change in insomnia severity

    This study will use the Chinese version of the Insomnia Severity Index (ISI-C). It consists of seven items, each rated from 0 to 4. Total scores range from 0 to 28, with higher scores indicating more severe insomnia; a score of 8 or higher indicates insomnia. Change is calculated as the day-21 score minus the day-1 score.

    Time frame: Baseline (day 1) and post-intervention (day 21)

Secondary outcomes

  1. Change in sleep latency

    Time from lying down to falling asleep, in minutes, measured with a wrist-worn actigraph and averaged over 7 nights for each period. Shorter sleep latency indicates better sleep; below 30 minutes is considered optimal.

    Time frame: Baseline (days 1-7) and follow-up (days 15-21)

  2. Change in total sleep time

    Total time in bed minus periods of wakefulness, in minutes, measured with a wrist-worn actigraph and averaged over 7 nights for each period. Longer total sleep time indicates better sleep.

    Time frame: Baseline (days 1-7) and follow-up (days 15-21)

  3. Change in sleep efficiency

    Total sleep time divided by time in bed × 100 (%), measured with a wrist-worn actigraph and averaged over 7 nights for each period. Higher values indicate better sleep; 85% or above is considered good.

    Time frame: Baseline (days 1-7) and follow-up (days 15-21)

  4. Change in depression

    This study will use the depression subscale of the Chinese version of the Depression Anxiety Stress Scales-21 (DASS-21). It consists of seven items rated from 0 (does not apply) to 3 (applies very much or most of the time). Subscale scores range from 0 to 21, with higher scores indicating more severe depression.

    Time frame: Baseline (day 1) and post-intervention (day 21)

  5. Change in anxiety

    This study will use the anxiety subscale of the Chinese version of the DASS-21. It consists of seven items rated from 0 to 3. Subscale scores range from 0 to 21, with higher scores indicating more severe anxiety.

    Time frame: Baseline (day 1) and post-intervention (day 21)

  6. Change in stress

    This study will use the stress subscale of the Chinese version of the DASS-21. It consists of seven items rated from 0 to 3. Subscale scores range from 0 to 21, with higher scores indicating more severe stress.

    Time frame: Baseline (day 1) and post-intervention (day 21)

07

Study locations

1 site
  • Shuang Ho Hospital, Taipei Medical University
    New Taipei City, Taiwan 235041, Taiwan
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share individual participant data from this study.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2022 to primary completion in Sep 2022, 4 months.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 4 months is below that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2026
First posted
Nov 20, 2026
StartActual
Apr 9, 2022
Primary completionActual
Sep 8, 2022
CompletionActual
Sep 8, 2022
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07950241
Responsible party
Minhuey Chung (Professor, Taipei Medical University) — Principal investigator
First posted
Nov 20, 2026
Start date
Apr 9, 2022
Primary completion
Sep 8, 2022
Completion
Sep 8, 2022
Last update
Nov 20, 2026

Study contacts

Min-Huey Chung, PhD
principal investigator · Taipei Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion